PKCs can have opposite effects on ERK phosphorylation. Novel (n)PKCs can inhibit ERK by phosphorylation of Raf-1, classical and atypical PKCs can activate ERK by removing an inhibitory protein from Raf-1. The aim of this work was to clarify how PMA-activated PKCs lead to ERK activation in MCF-7 cells expressing mainly nPKCs. Using chemical inhibitors and antibodies against PKCs, delivered into cells by the Chariot transfection system, we found that nPKCs activate ERK through transphosphorylation of PKD1, the blockage of which prevented PMA-stimulated ERK activation. We conclude that the nPKCs/PKD1 cascade is determinant for ERK activation by PMA in MCF-7 cells
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
<p><i>A</i>. Expression levels of the indicated mRNAs for the four novel PKCs were determined by RT-...
PKCs can have opposite effects on ERK phosphorylation. Novel (n)PKCs can inhibit ERK by phosphorylat...
PKCs can have opposite effects on ERK phosphorylation. Novel (n)PKCs can inhibit ERK by phosphorylat...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Abstract Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nucl...
Protein kinase C (PKC) has been shown to activate the mammalian target of rapamycin complex 1 (mTORC...
Abstract Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nucl...
Abstract Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nucl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
<p><i>A</i>. Expression levels of the indicated mRNAs for the four novel PKCs were determined by RT-...
PKCs can have opposite effects on ERK phosphorylation. Novel (n)PKCs can inhibit ERK by phosphorylat...
PKCs can have opposite effects on ERK phosphorylation. Novel (n)PKCs can inhibit ERK by phosphorylat...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, ...
Abstract Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nucl...
Protein kinase C (PKC) has been shown to activate the mammalian target of rapamycin complex 1 (mTORC...
Abstract Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nucl...
Abstract Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nucl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear transl...
<p><i>A</i>. Expression levels of the indicated mRNAs for the four novel PKCs were determined by RT-...